Outcomes of Intratympanic Gentamicin Injection to Treat Ménière’s Disease
Authors:
- Te-Yung FangTFTe-Yung Fang
- Pa-Chun WangPWPa-Chun Wang
- 1 July 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 33 (5) , 706-714
Abstract
To investigate the outcomes of intratympanic (IT) gentamicin sulfate injection to treat intractable Ménière's disease (MD) using evidence-based methods. Data were retrieved from a MEDLINE search (January 1995 through January 2011). Selected were English-language articles presenting outcomes of IT gentamicin injection to treat MD that had a prospective study design and an evidence level of II or higher. The database was searched using Boolean combinations of the keywords intratympanic, gentamicin, and Ménière's disease. Dichotomous outcomes (success rate and total deafness) were expressed using a Mantel-Haenszel fixed-effects model. Pretreatment and posttreatment pure-tone audiometry results, and word discrimination scores were summarized using data synthesis techniques. A critical literature appraisal and meta-analysis shows that IT gentamicin injection can control vertigo in patients with MD who have limited hearing injury. The quality of research in this field has improved remarkably over the years. However, a large-scale randomized controlled trial is warranted to confirm the predictive factors for the effectiveness of IT gentamicin injection in treating MD.Keywords
This publication has 18 references indexed in Scilit:
- Intratympanic gentamicin therapy for control of vertigo in unilateral Menière's disease: a prospective, double-blind, randomized, placebo-controlled trialActa Oto-Laryngologica, 2008
- Treatment of Ménière's Disease by Low‐Dosage Intratympanic Gentamicin Application: Effect on Otolith FunctionThe Laryngoscope, 2007
- Factors Relating to the Vertigo Control and Hearing Changes Following Intratympanic Gentamicin for Intractable Ménière's DiseaseOtology & Neurotology, 2006
- Intratympanic Gentamicin for Menière's Disease: a Meta‐AnalysisThe Laryngoscope, 2004
- Long‐Term Results after Interval Therapy with Intratympanic Gentamicin for Menière's DiseaseThe Laryngoscope, 2004
- Hearing Loss after Intratympanic Gentamicin Therapy for Unilateral Ménière's DiseaseOtology & Neurotology, 2003
- Long‐Term Hearing Outcome in Patients Receiving Intratympanic Gentamicin for Ménière's DiseaseThe Laryngoscope, 2003
- Intratympanic Therapy for Me´nie`re's Disease: Effect of Administration of Low Concentration of GentamicinActa Oto-Laryngologica, 2001
- Intratympanic Therapy for Ménière's Disease: High‐Concentration Gentamicin with Round‐Window ProtectionAnnals of the New York Academy of Sciences, 1999
- Intratympanic Gentamicin in Meniere's DiseaseActa Oto-Laryngologica, 1998